ArticleObesity surgery2025
Surgeons' Perspectives on Insurance Coverage for Metabolic and Bariatric Surgery in India: An Obesity and Metabolic Surgery Society of India (OSSI) Survey.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetabolic and bariatric surgery (MBS) is a proven and effective treatment for obesity and its related illnesses. In 2019, the Insurance Regulatory and Development Authority of India (IRDAI) mandated that MBS be covered under health insurance policies if specific medical criteria are met. However, real-world implementation of this policy is often inconsistent, with reports of claim denials and delays. This study aimed to assess Indian metabolic and bariatric surgeons' experiences with insurance coverage for metabolic and bariatric surgery.
methodsA cross-sectional survey was conducted among 109 members of the Obesity Surgery Society of India (OSSI) using a structured Google Form between November 2024 and March 2025. The questionnaire covered surgeon demographics, insurance experiences, patient patterns, and policy suggestions. Data were collected anonymously and analyzed using descriptive statistics.
resultsWhile 87.2% of respondents observed more patient interest after IRDAI's insurance mandate, only 9.2% reported that most of their patients used insurance. Low awareness, complex paperwork, and high out-of-pocket costs were major problems. 95.4% said patients delay surgery while waiting for insurance approval. The approval process was rated as complex or very complex by 69.7%. High denial rates were reported, often due to obesity exclusions or incomplete documentation. Nearly all respondents supported changes to improve the system, including faster approvals, fewer documentation requirements, and broader eligibility criteria such as lower BMI thresholds and inclusion of type 2 diabetes.
conclusionsDespite regulatory progress, insurance-related challenges like administrative delays, poor patient awareness, and inconsistent claim approvals continue to limit equitable access to MBS in India. Policymakers and insurers need to streamline processes and expand eligibility to ensure more people can benefit from this life-saving treatment.
Indexed as
Identifiers
41247585What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.